LexaGene Responds to Demand for Better Diagnostics for COVID-19
LexaGene has done in-house testing on its LX Analyzer using the CDC’s coronavirus test, and the company is also developing tests of its own for SARS-CoV-2.
Read More
Search Results for: infectious diseases
COVID-19: FDA Gives Flexibility to New York State Department of Health, Issues Emergency Use Authorization for Roche Diagnostic
FDA has exercised enforcement discretion to give the New York State Department of Health permission to authorize lab testing for COVID-19.
Read MoreApp, AI Work Together to Provide Rapid At-Home Assessment of Coronavirus Risk
A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they’ve been in about a minute, and direct those deemed at risk for COVID-19 to the nearest definitive testing facility, investigators say.
Read More
WHO Officially Calls Coronavirus a Pandemic
The World Health Organization is officially calling the novel coronavirus outbreak a pandemic.
Read MoreMesa Biotech Developing Molecular Point-of-Care Diagnostic Test for COVID-19
Building upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read More